Cooper LT. Clinical manifestations and diagnosis of myocarditis in adults. https://www.uptodate.com/contents/search. Accessed March 23, 2022.
Ammirati E, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy. Circulation. 2020; doi:10.1161/CIRCHEARTFAILURE.120.007405.
Cooper LT. Myocarditis: Causes and pathogenesis. https://www.uptodate.com/contents/search. Accessed March 23, 2022.
Siripanthong B, et al. Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020; doi:10.1016/j.hrthm.2020.05.001.
Cooper LT. Treatment and prognosis of myocarditis in adults. https://www.uptodate.com/contents/search. Accessed March 23, 2022.
Allan CK, et al. Clinical manifestations and diagnosis of myocarditis in children. https://www.uptodate.com/contents/search. Accessed March 23, 2022.
Bonow RO, et al., eds. Myocarditis. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Elsevier; 2019. https://www.clinicalkey.com. Accessed March 23, 2022.
Nguyen LS, et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nature Communications. 2022; doi:10.1038/s41467-021-27631-8.
Healthy habits to help prevent flu. Centers for Disease Control and Prevention. https://www.cdc.gov/flu/prevent/actions-prevent-flu.htm. Accessed March 23, 2022.
Cooper LT, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216.
Braswell-Pickering EA. Allscripts EPSi. Mayo Clinic. Feb. 28, 2022.
Mankad R (expert opinion). Mayo Clinic. April 13, 2022.
Cheng CY, et al. Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review. Autoimmunity Reviews. 2022; doi:10.1016/j.autrev.2022.103037.
Lopez-Jimenez F (expert opinion). Mayo Clinic. Nov. 29, 2021.
Myocarditis and pericarditis after mRNA COVID-19 vaccination. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html. Accessed April 13, 2022.
Hause AM, et al. Safety monitoring of COVID-19 vaccine booster doses among persons aged 12–17 years — United States, December 9, 2021-February 20, 2022. MMWR Morbidity and Mortality Weekly Report. 2022; doi: 10.15585/mmwr.mm7109e2.
Mouch SA, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021; doi:10.1016/j.vaccine.2021.05.087.
Mevorach D, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. The New England Journal of Medicine. 2021; doi:10.1056/NEJMoa2109730.
Lee ASY, et al. Myocarditis following COVID-19 vaccination: A systematic review (October 2020-October 2021). Heart, Lung and Circulation. 2022; doi:10.1016/j.hlc.2022.02.002.
COVID-19: Get the facts. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-vaccine/art-20484859. Accessed April 14, 2022.